A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of N1539 Following Bunionectomy

Trial Profile

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of N1539 Following Bunionectomy

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs Meloxicam (Primary)
  • Indications Postoperative pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Recro Pharma
  • Most Recent Events

    • 16 Apr 2018 According to a Recro Pharma media release, data from this trial will be presented at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting co-hosted by the American Society of Regional Anesthesia and Pain Medicine (ASRA).
    • 27 Mar 2018 Results presented in a Recro Pharma media release.
    • 27 Mar 2018 According to a Recro Pharma media release, results were published online in the Clinical Journal of Pain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top